The signal from the dividend investing community on Dividend.com is loud and clear. They are buying Medtronic.
Last week’s meteoric rise from the 77th position to the 69th position is a testament to how appealing Medtronic is to investors right now. In September of last year, this stock was ranked a measly 91st on this list. Today, it is up 21 positions. Medtronic scores high on every major dividend-specific parameter that an investor would evaluate. With $115 billion in market cap, the medical equipment and appliances company is in the big league. The stock is yielding more than double the healthcare average. Its yield is at par with what the broader market is currently offering. Its dividend profile is impressive, with a phenomenal 40 consecutive years of dividend growth. Moreover, its payout ratio of just under 40% still leaves ample room for the company to both grow its dividend and re-invest its earnings to grow more. The stock price is also hovering near its all-time high. With all these factors going its way, one would expect the stock to be quite expensive. But, in fact, it’s quite the opposite. Medtronic is only trading at a forward-looking P/E of 17, which sounds too good to be true.
Other stocks that moved up on the list are also regulars. General Mills is up two places from 52 to 50. Union Pacific is up two places from 88 to 86 and IBM Corp is up two places from 46 to 44.
Our Most Watched Stocks List is a user-generated, interest-based ranking of dividend-paying stocks, giving you a real-time snapshot of buying interest in the market. Generated by our Premium members’ watchlists, it’s aggregated and ranked by the most watched criteria.
The list has been designed to help income investors navigate the top dividend stocks being tracked by one of the world’s most advanced investing communities.